10:20-10:40 | EBV and MS: Molecular mimicry and beyond
Tobias Lanz (Stanford School of Medicine – Stanford, CA, USA)
10:40-11:00 | CNS-resident memory T cells in neuroinflammatory diseases
Roland Liblau (Toulouse University Hospital – Toulouse, France)
11:00-11-20 | ME/CFS and Long Covid: the role of autoimmunity
Carmen Scheibenbogen (Charité – Universitätsmedizin Berlin – Berlin, Germany)
11:20-11:40 | TBD
Roland Martin (University of Zurich – Zürich, Switzerland / Karolinska Institutet – Stockholm, Sweden / Cellerys AG – Schlieren, Switzerland)
11:40-12:00 | O-345 | Cytomegalovirus drives the development of natalizumab-resistant cytotoxic CD4+ T cells in patients with multiple sclerosis
Niels Hellings (Biomedical Research Institute (BIOMED) & University MS Center (UMSC), Hasselt University – Diepenbeek, Belgium)